Robotic Point-of-Care OCT
机器人床旁 OCT
基本信息
- 批准号:10507461
- 负责人:
- 金额:$ 9.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAge related macular degenerationAlgorithmsAmericanAnatomyAreaAttenuatedBlindedBlindnessBlinkingCaringChronicClinicClinicalComputer softwareDetectionDevice or Instrument DevelopmentDiabetic RetinopathyDiagnostic ProcedureDiseaseDisease ManagementDisease SurveillanceEnsureEnvironmentExcisionExhibitsEyeEye diseasesFaceFundingGenerationsGlaucomaHandHeadHealth PersonnelHuman ResourcesImageImaging TechniquesInternshipsLaboratoriesMachine LearningMeasurementMeasuresMechanicsMedicalMedical DeviceMedical TechnologyMentorsMorphologic artifactsMotionOphthalmic examination and evaluationOphthalmologistOphthalmologyOptical Coherence TomographyOpticsPatient ParticipationPatient imagingPatientsPatients&apos RoomsPhasePositioning AttributePredispositionPrimary Health CareProcessResearchResearch PersonnelResidual stateRetinaRetinal DiseasesRobotRoboticsRoleScanningScientistSignal TransductionSpecialistStructureSystemTechniquesTechnologyTestingTimeTorqueTrainingTraining ProgramsTranslatingVisionVisitarmattenuationbasecare providerscareercareer developmentdigitalexperiencefeedingflexibilityhead-to-head comparisonimage processingimaging modalityimaging platformimaging systemimprovedinstrumentmedical schoolsnext generationnovelnovel strategiesoperationpoint of careportabilitypreventprimary care settingprogramsprototyperesearch clinical testingroutine screeningscreeningstandard of caretechnology developmentteleophthalmologytoolvisual tracking
项目摘要
PROJECT SUMMARY/ABSTRACT
The PI was previously funded by the F30 mechanism while completing the Duke Medical Scientist Training
Program. He has since completed medical school and internship and now returns for a full-time research career.
This career development proposal is an effective continuation of the PI’s prior mentored training and research
experience and seeks to develop him into an independent investigator. The proposed project concerns the role
of optical coherence tomography (OCT) in retinal disease screening. Preventable retinal blindness affects tens
of millions of Americans and hundreds of millions worldwide. Its top three causes are chronic, progressive
conditions that yield irreversible vision loss after an initial asymptomatic period. Annual screening is therefore
essential to detect and treat these diseases before sight deteriorates. Rates of screening are suboptimal,
however, because the proper eye examination is difficult for and inaccurate when performed by primary care
providers (PCPs). OCT is an essential imaging modality for management of retinal diseases. Currently, clinical
OCT is deployed as bulky tabletop instruments that require trained ophthalmic photographers, dedicated imaging
suites, and mechanical head stabilization with chinrests for operation, which has prevented OCT-based eye
screening by PCPs. We recently introduced robotic point-of-care OCT (RAOCT) as a fundamentally new
paradigm for OCT-based eye examination that overcomes the barriers that restrict OCT to ophthalmology offices.
RAOCT offers semi- or fully-automated non-contact OCT imaging by bringing a robot-mounted OCT scanner to
the patient, tracking them throughout a large imaging workspace, and optically correcting for motion artifact. Our
laboratory prototypes using this approach have demonstrated sufficient OCT quality in freestanding and seated
subjects for anatomic measurement and clinical correlation, respectively, with only minimal operator training.
These prototypes function reliably only under controlled laboratory conditions, however, and significant
technology development for portability, tracking robustness, and motion correction is necessary to yield a clinic-
ready instrument. This project therefore seeks to advance our bench-mounted prototypes into fully-fledged
mobile systems for imaging in non-specialist clinics and to test them against the OCT standard-of-care. First, we
will transition our prototype into a wheeled cart that can be brought into clinics, upgrade our robot arm for
extended reach, and redesign our robot-mounted scanner for improved tracking under realistic imaging
conditions. Next, we will enhance motion attenuation by transitioning image processing algorithms to dedicated
hardware, by adding digital correction for residual motion, and by incorporating a novel adaptive scanning
technique to reduce imaging time. Finally, we will perform RAOCT imaging in ophthalmology clinics to compare
against the standard of care and in primary care offices to evaluate screening workflows. Completion of this
project will develop robotic point-of-care OCT into a turnkey imaging platform that promises to enhance eye
screening in primary care settings.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Draelos其他文献
Mark Draelos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Draelos', 18)}}的其他基金
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 9.78万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 9.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 9.78万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 9.78万 - 项目类别:














{{item.name}}会员




